Healthways, Inc. (TVTY) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Healthways, Inc. (NASDAQ:TVTY) from a sell rating to a hold rating in a report published on Thursday morning.

According to Zacks, “Tivity Health, Inc. provides health management services. The company offers services which include chiropractic services, physical therapy, occupational therapy, speech therapy, acupuncture, massage and complementary and alternative medicine services. Its network comprises SilverSneakers(R), Prime(R) Fitness and WholeHealth Living (TM). Tivity Health, Inc., formerly known as Healthways, Inc., is based in Franklin, Tennessee. “

Other research analysts have also recently issued reports about the company. UBS AG upped their price objective on Healthways from $37.00 to $43.00 and gave the stock a buy rating in a research report on Friday, June 23rd. Jefferies Group LLC reaffirmed a buy rating and set a $36.00 price objective on shares of Healthways in a research report on Friday, June 16th. ValuEngine raised Healthways from a hold rating to a buy rating in a research report on Friday, September 1st. Chardan Capital started coverage on Healthways in a research report on Tuesday, August 29th. They set a neutral rating and a $40.00 price objective for the company. Finally, Barrington Research upped their price objective on Healthways from $35.00 to $44.00 and gave the stock an outperform rating in a research report on Friday, July 28th. Three analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of Buy and an average target price of $41.57.

Shares of Healthways (TVTY) traded down 0.72% during midday trading on Thursday, reaching $41.25. The company’s stock had a trading volume of 233,744 shares. Healthways has a 12-month low of $19.25 and a 12-month high of $43.00. The stock’s 50-day moving average price is $39.05 and its 200-day moving average price is $35.82. The company has a market cap of $1.62 billion, a P/E ratio of 34.38 and a beta of 0.38.

Healthways (NASDAQ:TVTY) last released its quarterly earnings data on Thursday, July 27th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.38 by $0.03. The business had revenue of $138.90 million during the quarter, compared to analysts’ expectations of $138.15 million. Healthways had a return on equity of 29.81% and a net margin of 17.30%. The firm’s quarterly revenue was up 11.1% on a year-over-year basis. On average, analysts expect that Healthways will post $1.53 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States & international copyright & trademark legislation. The legal version of this news story can be viewed at https://ledgergazette.com/2017/10/08/healthways-inc-tvty-upgraded-at-zacks-investment-research.html.

In related news, Director Conan Laughlin sold 1,750,000 shares of the company’s stock in a transaction dated Tuesday, August 1st. The stock was sold at an average price of $37.90, for a total value of $66,325,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Mary Flipse sold 1,340 shares of the company’s stock in a transaction dated Friday, August 11th. The shares were sold at an average price of $37.32, for a total value of $50,008.80. Following the completion of the sale, the insider now directly owns 75,187 shares of the company’s stock, valued at $2,805,978.84. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,824,858 shares of company stock valued at $69,172,017. Insiders own 8.42% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. acquired a new stake in shares of Healthways in the 1st quarter valued at about $135,544,000. BlackRock Inc. acquired a new stake in shares of Healthways in the 1st quarter valued at about $123,015,000. North Tide Capital LLC acquired a new stake in shares of Healthways in the 1st quarter valued at about $72,750,000. Dimensional Fund Advisors LP acquired a new stake in shares of Healthways in the 1st quarter valued at about $70,660,000. Finally, JPMorgan Chase & Co. acquired a new stake in shares of Healthways in the 1st quarter valued at about $34,618,000.

About Healthways

Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.

Get a free copy of the Zacks research report on Healthways (TVTY)

For more information about research offerings from Zacks Investment Research, visit

According to Zacks, “Tivity Health, Inc. provides health management services. The company offers services which include chiropractic services, physical therapy, occupational therapy, speech therapy, acupuncture, massage and complementary and alternative medicine services. Its network comprises SilverSneakers(R), Prime(R) Fitness and WholeHealth Living (TM). Tivity Health, Inc., formerly known as Healthways, Inc., is based in Franklin, Tennessee. “

Other research analysts have also recently issued reports about the company. UBS AG upped their price objective on Healthways from $37.00 to $43.00 and gave the stock a buy rating in a research report on Friday, June 23rd. Jefferies Group LLC reaffirmed a buy rating and set a $36.00 price objective on shares of Healthways in a research report on Friday, June 16th. ValuEngine raised Healthways from a hold rating to a buy rating in a research report on Friday, September 1st. Chardan Capital started coverage on Healthways in a research report on Tuesday, August 29th. They set a neutral rating and a $40.00 price objective for the company. Finally, Barrington Research upped their price objective on Healthways from $35.00 to $44.00 and gave the stock an outperform rating in a research report on Friday, July 28th. Three analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of Buy and an average target price of $41.57.

Shares of Healthways (TVTY) traded down 0.72% during midday trading on Thursday, reaching $41.25. The company’s stock had a trading volume of 233,744 shares. Healthways has a 12-month low of $19.25 and a 12-month high of $43.00. The stock’s 50-day moving average price is $39.05 and its 200-day moving average price is $35.82. The company has a market cap of $1.62 billion, a P/E ratio of 34.38 and a beta of 0.38.

Healthways (NASDAQ:TVTY) last released its quarterly earnings data on Thursday, July 27th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.38 by $0.03. The business had revenue of $138.90 million during the quarter, compared to analysts’ expectations of $138.15 million. Healthways had a return on equity of 29.81% and a net margin of 17.30%. The firm’s quarterly revenue was up 11.1% on a year-over-year basis. On average, analysts expect that Healthways will post $1.53 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States & international copyright & trademark legislation. The legal version of this news story can be viewed at https://ledgergazette.com/2017/10/08/healthways-inc-tvty-upgraded-at-zacks-investment-research.html.

In related news, Director Conan Laughlin sold 1,750,000 shares of the company’s stock in a transaction dated Tuesday, August 1st. The stock was sold at an average price of $37.90, for a total value of $66,325,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Mary Flipse sold 1,340 shares of the company’s stock in a transaction dated Friday, August 11th. The shares were sold at an average price of $37.32, for a total value of $50,008.80. Following the completion of the sale, the insider now directly owns 75,187 shares of the company’s stock, valued at $2,805,978.84. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,824,858 shares of company stock valued at $69,172,017. Insiders own 8.42% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. acquired a new stake in shares of Healthways in the 1st quarter valued at about $135,544,000. BlackRock Inc. acquired a new stake in shares of Healthways in the 1st quarter valued at about $123,015,000. North Tide Capital LLC acquired a new stake in shares of Healthways in the 1st quarter valued at about $72,750,000. Dimensional Fund Advisors LP acquired a new stake in shares of Healthways in the 1st quarter valued at about $70,660,000. Finally, JPMorgan Chase & Co. acquired a new stake in shares of Healthways in the 1st quarter valued at about $34,618,000.

About Healthways

Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.

Get a free copy of the Zacks research report on Healthways (TVTY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Healthways (NASDAQ:TVTY)

Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.